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 ABSTRACT                                                                                                                                            
Progressive osseous heteroplasia (POH): an Egyptian 
patient
Ezzat El Sobky and Solaf M. El Sayed
Genetics Unit, Children’s hospital, Ain Shams University
Progressive osseous heteroplasia is a rare genetic disorder characterized by cu-
taneous ossification during infancy and progressive ossification of subcutane-
ous and deep connective tissue including muscle and fascia during childhood. 
It is at the severe end of a spectrum of Guanine Nucleotide-binding protein, 
Alpha-Stimulating activity polypeptide (GNAS) associated ossification disor-
ders that include osteoma cutis and Albright hereditary osteodystrophy. Here 
we describe a five year old boy with progressive ossification of skin and subcu-
taneous tissue and progressive limitation of movement of all joints. X-rays re-
vealed extensive calcification of cutaneous and subcutaneous tissues involving 
nearly the whole body. As far as our knowledge, no cases have been reported 






Progressive osseous heteroplasia, 
GNAS1 mutations, Heterotopic ossifi-
cation.
INTRODUCTION                                                                     
Progressive osseous heteroplasia (POH) 
is a rare disorder of mesenchymal differ-
entiation characterized by dermal ossifi-
cation beginning in infancy and consists 
of maculopapular rashes at sites of fu-
ture ossification, followed by increasing 
and extensive bone formation in deep 
muscle and fascia. Dermal lesions co-
alesce rapidly to form extensive ossified 
plaques.1
CASE REPORT                                                                     
Our case is a five year old boy, the first 
born after uncomplicated pregnancy to 
non-consanguineous healthy parents. 
The patient has a younger normal 4 year 
old brother and no similar affected fam-
ily members. 
His condition started at the age of 2 
years when he developed hardened cuta-
neous lesions that coalesced into plaques 
and extended rapidly all over his body 
with subsequent ulcerations through the 
epidermis. This was associated with pro-
gressive loss of motor skills. On exami-
nation, the patient had ossified plaques 
and ulcers all over the trunk and limbs 
and limited movement of nearly all 
joints with flexion deformity. He was un-
able to walk or to move his upper limbs. 
Neurological examination revealed no 
abnormalities. There was no facial dys-
morphism or digital malformation 
Serum levels of calcium and phospho-
rus were normal as well as parathyroid 
hormone level. X-rays showed extensive 
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diffuse cutaneous and subcutaneous 
web-like calcification surrounding all 
the upper and lower limbs and sparing 
only the soft tissue areas around hands 
and feet, (Figs. 1: A, B, C).
Unfortunately, the condition of the pa-
tient progressed rapidly with extensive 
ulceration of the skin and subcutaneous 
tissue that was associated with second-
ary infection which ended by his death 
shortly after presentation to our clinic.
Fig. 1 (A, B, C): Radiographs of the patient showing tiny radiodensities seen in skin and soft connective 
tissues of nearly all body extending from the dermis down through the skeletal muscle sparing only the 
hands and feet.
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DISCUSSION                                                                      
Our patient has typical features of POH 
described by Kaplan, et al. 1994 with 
heterotopic ossification involving sub-
cutaneous and deep connective tissues, 
including muscle and fascia, in the ab-
sence of multiple features of Albright 
hereditary osteodystrophy (AHO) or 
hormone resistance1. Usually, the first 
symptoms occur in childhood (Birth to 
3 years) and girls appear to be more af-
fected than boys.2 
Differential diagnosis include fibro-
dysplasia ossificans progressive (FOP), 
which is another rare autosomal domi-
nant condition of heterotopic ossifica-
tion and can readily be distinguished 
by the absence of cutaneous ossifica-
tion, the congenital malformation of 
the great toes and the presence of pre-
osseous tumor-like inflammation or 
“Flare-ups”3. Triggering factors such as 
trauma, infection or needle punctures 
do not seem to occur in POH as they 
do in FOP.1 
The heterotopic ossification of POH is 
predominantly intramembranous and 
involves subcutaneous and deep tissues 
but not the viscera4. In contrast, the het-
erotopic ossification in FOP is predomi-
nantly enchondral.3
Although differential diagnosis may 
includes pseudopseudohypoparathy-
roidism (PPHP) or Albright hereditary 
osteodystrophy (AHO) because it is 
caused by mutation of the same gene, 
patients with PPHP have a constellation 
of physical findings that is often not 
seen in patients with POH. It has been 
suggested that POH may be an extreme 
end of the spectrum of the AHO fea-
tures seen in PPHP.5
The results of laboratory studies in our 
patient were normal and he had normal 
height, normal phenotype and normal 
great toe with no flare ups or tumour 
like inflammations supporting the diag-
nosis of POH and excluding other di-
agnoses such as PPHP, AHO and FOP.
Most of POH cases are caused by het-
erozygous inactivating mutations of 
GNAS1, the gene encoding the alpha 
subunit of the G-stimulatory protein of 
adenyl cyclase. The defective allele in 
POH is inherited exclusively from fa-
thers, a result consistent with a model of 
imprinting for GNAS1. The same muta-
tion can cause either POH or AHO fea-
tures depending on the parental origin 
of the mutant allele6. Faust, et al. (2003) 
identified a heterozygous germline mu-
tation in the GNAS1 gene causing POH 
of the face in an Albanian girl.7 
Cases of patients with combined fea-
tures of POH and AHO have been re-
ported8. Stoll, et al. reported the clinical 
and radiologic features of a patient with 
POH who was 20 years old at presenta-
tion. In addition to abnormal ossifica-
tions, she had short metacarpals at the 
fourth and fifth rays and short meta-
tarsals at the second rays. Her parents 
were unaffected.9 
POH has been observed in sporadic 
cases and in an autosomal dominant 
pedigree pattern with widely variable 
expression11. In this present family with 
healthy parents, the disease is most 
probably due to new mutation with rare 
recurrence risk.
There are no specific genotype-pheno-
type correlations that distinguished the 
more progressive forms such as POH, 




Physiotherapy to preserve movement 
and the prevention of skin breakdown 
is the only currently acceptable therapy. 
There is no reliable treatment or preven-
tion for POH3. Although areas of well-
circumscribed heterotopic ossification 
can sometimes be removed successful-
ly, the surgical removal of POH tissue 
has led to recurrence in most patients, 
notably when the heterotopic ossifica-
tion is diffuse and web-like rather than 
focal4. Amputations have been done in 
some children.3
The present patient had a severe pro-
gressive course that ended eventually 
by his death at the age of 5 years. The 
long-term prognosis of POH is uncer-
tain because only few patients have 
been followed-up beyond adolescence, 
but, in these cases, the disease has fol-
lowed a course of slower progression 
during adulthood11,12. Kaplan, et al. 
mentioned that, in patients with an ear-
ly onset of the disease, progression had 
generally ceased by adulthood.3 
Early diagnosis is important for ge-
netic counseling and for prevention of 
iatrogenic harm. Patients and relatives 
should be given adequate counseling 
particularly with regard to education as 
the patients are not mentally impaired 
and because the disease does not seem 
to progress rapidly in the adult.
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